Eur Rev Med Pharmacol Sci 2022; 26 (1 Suppl): 113-118
DOI: 10.26355/eurrev_202211_30290

Treatment options for proximal periprosthetic femoral fractures in Total Hip Arthroplasty: a single center experience

S. Marino, A. Giuliani, D. De Mauro, G. Rovere, A. Smakaj, G.M. Sassara, L. Are, G. Maccauro, F. Liuzza

Department of Aging, Neurological, Orthopedic and Head-Neck Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. amarildo.smakaj@gmail.com


OBJECTIVE: Proximal periprosthetic femoral fractures (PPFFs) are gradually increasing and surgical management is often associated with high risk of complications, due to elderly population and associated comorbidities.

PATIENTS AND METHODS: We retrospectively assessed 39 patients at least at 2-years follow-up. We identified two study groups, similar for demographic data. Group A included patients surgically treated without involving prosthetic implants, whereas Group B included patients in which an implant revision was performed.

RESULTS: Data were recorded from January 2017 to February 2020, and 39 patients were included: 30 females (76.9%) and 9 males (23.1%), with a confirmed diagnosis of periprosthetic fracture of the proximal femur. 23 (58.9%) patients were treated with Open Reduction and Internal Fixation (ORIF), 12 (30.7%) with revision surgery and 4 (10.3%) were treated by modular megaprosthesis.

CONCLUSIONS: The treatment options considered in the study, revision arthroplasty and internal fixation had shown no significant differences as a matter of clinical outcomes and postoperative complications.

Published on: 2022/11/29


Free PDF Download

To cite this article

S. Marino, A. Giuliani, D. De Mauro, G. Rovere, A. Smakaj, G.M. Sassara, L. Are, G. Maccauro, F. Liuzza
Treatment options for proximal periprosthetic femoral fractures in Total Hip Arthroplasty: a single center experience

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 1 Suppl
Pages: 113-118
DOI: 10.26355/eurrev_202211_30290